Generic Pharmaceuticals Company Equity Stake For Sale in Hyderabad, India

Core products include homeopathic OTC remedies such as dilutions, pellets, tablets, and blank sugar globules, targeting global retail consumers purchasing via e-commerce platforms, as well as potential B2B buyers seeking pharmaceutical-grade excipients enabled by the company’s US FDA Drug Master File. Intangible assets (Key Value Drivers):

Registered Trademark (USA & Other Countries) - A protected global brand with 30 years of market presence, consumer trust and high customer ratings across major platforms.
US FDA Drug Master File (Type IV - Homoeopathic Blank Pellets) - Filed in December 2022. A rare and strategically valuable regulatory asset enabling the supply of pharmaceutical-grade sugar globules to homoeopathic manufacturers worldwide. Very few companies globally hold this designation. The manufacturer is a 3rd party, but the DMF can be extended to multiple manufacturing partner sites.
Thousands of US FDA-listed drug products are listed - All products listed under the Homoeopathic Pharmacopoeia of the United States (HPUS), with drug facts publicly available on the US National Library of Medicine's DailyMed database. This regulatory portfolio represents years of investment and cannot be easily replicated by a new market entrant.
3-Country Legal and Corporate Infrastructure - Active legal entities in the USA, India and Canada, providing a ready-to-scale platform for global expansion without the need to establish new corporate structures from scratch.
Proprietary E-Commerce Platform - Scalable, integrated technology infrastructure connected to production systems and third-party marketplaces.
US FDA Establishment Registration - The India-based manufacturing facility is formally registered with the US FDA.
Marketplace Presence & Goodwill - Established storefronts with high ratings on Amazon, eBay and Walmart, representing significant digital brand equity built over many years.
Domain Names & Digital Assets - Multiple country-specific and global web domains and associated digital properties.

Tangible assets:

Own Manufacturing facility (small-scale manufacturing) worth INR 5 crores.
Manufacturing and production equipment at the India facility worth INR 3 crores. India (Manufacturing) - Hyderabad India: A US FDA-registered and inspected manufacturing and export facility operating under strict cGMP guidelines. The facility handles end-to-end production - from mother tinctures to dilutions to finished medicated pellets - with full traceability documentation at every stage. Own premises.

USA (Fulfillment/Distribution) - Texas: A third-party logistics (3PL) warehouse facility that has been FDA-inspected without any observations. Capable of processing thousands of orders per day with no space constraints on SKU count or inventory volume.

Canada (Warehouse/Distribution) - Ontario: Company and a third-party logistics (3PL) warehouse setup completed in 2021, serving the Canadian market. • India (Manufacturing) – Hyderabad: US FDA-registered and inspected manufacturing and export facility operating under strict cGMP guidelines. Handles end-to-end production from mother tinctures to dilutions to finished medicated pellets, with full traceability at every stage. Facility is company-owned.

• USA (Fulfillment/Distribution) – Texas: Third-party logistics (3PL) warehouse that has been FDA-inspected with no observations. Capable of processing thousands of orders per day with no constraints on SKU count or inventory volume.

• Canada (Warehouse/Distribution) – Ontario: Company-established presence supported by a third-party logistics (3PL) warehouse setup, serving the Canadian market.